Global Literature Monitoring.
Patient safety means we’re always watching, everywhere.
Literature monitoring is more than just a drug safety regulatory obligation, it provides insight into all safety issues and promotes the creation of various types of safety and aggregate reports.
It supports the signal management process, and influences decisions that mitigate the risk-benefit balance of your product, ultimately helping to protect patients.
Global Literature Monitoring (GLM) is a key element of a pharmacovigilance system and Arriello provides a complete GLM service, including monitoring of the EMA’s Medical Literature Monitoring (MLM) service, with full text review and assessment of safety information.
Our extensive experience in developing robust search strategies and the construction of optimised literature queries allows us to search for published studies and information specifically relevant to the safety of your products.